117 related articles for article (PubMed ID: 8534045)
1. Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen.
Seifart HI; Donald PR; de Villiers JN; Parkin DP; Jaarsveld PP
Ann Trop Paediatr; 1995 Sep; 15(3):249-54. PubMed ID: 8534045
[TBL] [Abstract][Full Text] [Related]
2. Hydrazine production in children receiving isoniazid for the treatment of tuberculous meningitis.
Donald PR; Seifart HI; Parkin DP; van Jaarsveld PP
Ann Pharmacother; 1994 Dec; 28(12):1340-3. PubMed ID: 7696721
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status.
Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP
Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of rifampicin and isoniazid in tuberculosis.
Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
Roy V; Tekur U; Chopra K
Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid pharmacokinetics in children according to acetylator phenotype.
Rey E; Gendrel D; Treluyer JM; Tran A; Pariente-Khayat A; d'Athis P; Pons G
Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of isoniazid and pyrazinamide in children: impact of age and nutritional status.
Dayal R; Singh Y; Agarwal D; Kumar M; Swaminathan S; Ramachandran G; Kumar S; Narayan S; Goyal A; Kumar AKH
Arch Dis Child; 2018 Dec; 103(12):1150-1154. PubMed ID: 29514812
[TBL] [Abstract][Full Text] [Related]
8. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
Ramachandran G; Hemanth Kumar AK; Bhavani PK; Poorana Gangadevi N; Sekar L; Vijayasekaran D; Banu Rekha VV; Ramesh Kumar S; Ravichandran N; Mathevan G; Swaminathan S
Int J Tuberc Lung Dis; 2013 Jun; 17(6):800-6. PubMed ID: 23676165
[TBL] [Abstract][Full Text] [Related]
9. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
10. Intensive short course chemotherapy in the management of tuberculous meningitis.
Donald PR; Schoeman JF; Van Zyl LE; De Villiers JN; Pretorius M; Springer P
Int J Tuberc Lung Dis; 1998 Sep; 2(9):704-11. PubMed ID: 9755923
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
Padilha EC; Pires RV; Filho MA; de Pontes Machado DV; Baldan HM; Davanço MG; Campos ML; Brunetti IL; Peccinini RG
Biopharm Drug Dispos; 2012 Dec; 33(9):501-9. PubMed ID: 23007681
[TBL] [Abstract][Full Text] [Related]
12. [A case of refractory tuberculous meningitis markedly improved by intrathecal administration of isoniazid (INH)].
Takahashi T; Ogawa K; Sawada S; Nakayama T; Mizutani T
Rinsho Shinkeigaku; 2003; 43(1-2):20-5. PubMed ID: 12820546
[TBL] [Abstract][Full Text] [Related]
13. [Isoniazid therapy and monitoring plasma levels].
Lamedica G; Penco G; Spandonari MM; Jannuzzi C
Pediatr Med Chir; 1984; 6(1):103-8. PubMed ID: 6335749
[TBL] [Abstract][Full Text] [Related]
14. Blood levels of isoniazid in Indian children with tuberculosis.
Rangari GM; Roy V; Sethi GR; Mishra TK; Khanna A
Indian J Tuberc; 2015 Apr; 62(2):80-5. PubMed ID: 26117476
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
Heemskerk AD; Nguyen MTH; Dang HTM; Vinh Nguyen CV; Nguyen LH; Do TDA; Nguyen TTT; Wolbers M; Day J; Le TTP; Nguyen BD; Caws M; Thwaites GE
Clin Infect Dis; 2017 Jul; 65(1):20-28. PubMed ID: 28472255
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.
McIlleron H; Willemse M; Werely CJ; Hussey GD; Schaaf HS; Smith PJ; Donald PR
Clin Infect Dis; 2009 Jun; 48(11):1547-53. PubMed ID: 19392636
[TBL] [Abstract][Full Text] [Related]
18. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
Baldan HM; De Rosa HJ; Brunetti IL; Ximenes VF; Machado RG
Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of tuberculous meningitis in children and adults.
Donald PR
Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid pharmacokinetic studies of the 1960s: considering a higher isoniazid dose in childhood tuberculosis.
Thee S; Detjen AA; Wahn U; Magdorf K
Scand J Infect Dis; 2010 Apr; 42(4):294-8. PubMed ID: 20100111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
